Oral contraceptive use and malignancies of the genital tract. Results from The Royal College of General Practitioners' Oral Contraception Study

1989 ◽  
Vol 29 (2) ◽  
pp. 199-199
Author(s):  
V Beral ◽  
P Hannaford ◽  
C Kay
Keyword(s):  
Oral Contraceptive ◽  
General Practitioners ◽  
Royal College ◽  
Genital Tract ◽  
Contraceptive Use ◽  
Oral Contraception ◽  
Oral Contraceptive Use

Oral Contraceptive Use and Malignancies of the Genital Tract

1989 ◽  
Vol 44 (6) ◽  
pp. 465-467
Author(s):  
VALERIE BERAL ◽  
PHILIP HANNAFORD ◽  
CLIFFORD KAY
Keyword(s):  
Oral Contraceptive ◽  
Genital Tract ◽  
Contraceptive Use ◽  
Oral Contraceptive Use

Does the Use of Oral Contraception Depress DZ Twinning Rates?

1987 ◽  
Vol 36 (3) ◽  
pp. 409-415 ◽  
Author(s):  
D. Campbell ◽  
B. Thompson ◽  
C. Pritchard ◽  
M. Samphier
Keyword(s):  
Oral Contraceptive ◽  
Oral Contraceptives ◽  
Early Pregnancy ◽  
Contraceptive Use ◽  
Oral Contraception ◽  
Secular Trends ◽  
Control Groups ◽  
Blood Samples ◽  
Oral Contraceptive Use

AbstractData based on total births from a geographically defined population with zygosity determined from blood samples and placentation and with data on the use of oral contraceptives routinely collected in early pregnancy showed no association between oral contraceptive use prior to pregnancy in either MZ or DZ twinning. Three mutually exclusive control groups of singletons were used to take account of age, parity and secular trends.

ORAL CONTRACEPTIVE USE AND MALIGNANCIES OF THE GENITAL TRACT

The Lancet ◽  
1988 ◽  
Vol 332 (8624) ◽  
pp. 1331-1335 ◽  
Author(s):  
Valerie Beral ◽  
Philip Hannaford ◽  
Clifford Kay
Keyword(s):  
Oral Contraceptive ◽  
Genital Tract ◽  
Contraceptive Use ◽  
Oral Contraceptive Use

Plasminogen Activator Levels in Plasma and Urine during Exercise and Oral Contraceptive Use

1978 ◽  
Vol 39 (03) ◽  
pp. 743-750 ◽  
Author(s):  
Anne M Hedlin ◽  
Susan Milojevic ◽  
Andrew Korey
Keyword(s):  
Oral Contraceptive ◽  
Plasminogen Activator ◽  
Contraceptive Use ◽  
Ethinyl Estradiol ◽  
Plasminogen Activators ◽  
Oral Contraceptive Use ◽  
Ethynodiol Diacetate

SummaryThe effect of Demulen (ethinyl estradiol 0.05 mg and ethynodiol diacetate 1 mg) and exercise on the level of plasminogen activators was studied in 25 women (12 controls and 13 contraceptive users).Plasma plasminogen activator level was increased by the use of the oral contraceptive and further increased by exercise. Urine plasminogen activator level was unchanged by the use of Demulen but, in both groups of subjects, was decreased by exercise.

Sign in / Sign up

Export Citation Format

Share Document